Position
Squarepoint Ops LLC in Inmune Bio, Inc.
Back to the book · All holders of INMB
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$5.72K$1.56 → $1.13
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 13.3K | $20.7K | — | — | — | 0.0% |
| Q1 2026 | 16K | $18.1K | $1.13 | −$5.72K | $3.09K | 0.0% |